Molecular Partners AG (MOLN) Financials

MOLN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 238.2 million 23.9 million
2023-06-30 256.4 million 27.3 million
2023-03-31 267.5 million 24.5 million
2022-12-31 283.7 million 29.3 million

MOLN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -14.6 million 1.1 million
2023-06-30 -15.0 million 1.5 million
2023-03-31 -18.3 million 1.9 million
2022-12-31 -16.1 million 1.2 million

MOLN Net Income

No data available :(

MOLN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 225.7 million - 4.3 million
2023-06-30 242.7 million - 4.7 million
2023-03-31 254.2 million - 5.0 million
2022-12-31 269.5 million - 5.2 million

MOLN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 35.9 million
2023-06-30 36.5 million
2023-03-31 35.6 million
2022-12-31 35.2 million

MOLN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 170388 12.7 million 4.8 million -
2023-06-30 202447 12.9 million 5.2 million -
2023-03-31 175052 13.9 million 982085 1.4 million
2022-12-31 680315 13.2 million 5.4 million -

MOLN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 2.8 million 12.7 million
2023-06-30 461625 12.9 million
2023-03-31 3.3 million 13.9 million
2022-12-31 2.9 million 13.2 million

MOLN

Price: $3.98

52 week price:
3.32
7.32

Earnings Per Share: -2.10 USD

P/E Ratio: -2.11

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 4126

Market Capitalization: 129.8 million

Links: